Menu

Ruth Nussenzweig, Malaria Researcher, Dies

The microbiologist’s research led to the development of the first human malaria vaccine.

Apr 5, 2018
Jim Daley

NYU LANGONE HEALTH

Ruth Nussenzweig, a leader in the worldwide fight against malaria, died earlier this month (April 1). She was 89 years old.

Nussenzweig, a professor emerita of microbiology and pathology at New York University’s Langone Medical Center, was chair of the department of medical and molecular parasitology for nearly 20 years—the first woman to hold the position. She was elected to the Health and Medicine Division of the National Academies in 2006 and the National Academy of Sciences in 2013.

“Her work in the field of immunology serves as a guide for the development of a new generation of recombinant vaccines,” Maurício Martins Rodrigues told Agência FAPESP in 2013.

Nussenzweig was born in 1928 to Jewish parents in Vienna. In 1939, her family fled to Brazil after Nazi Germany annexed Austria. When she was 18 years old, she enrolled in the medical school of the University of São Paulo, where she met Victor Nussenzweig, according to Planeta Universeitario. The two later married and collaborated together on immunology research for the next sixty years.

Over the course of her career, Nussenzweig dedicated herself to disease prevention and treatment. In 1967, she discovered that immunizing animals with irradiated Plasmodium berghei sporozoites protected the animals from the malaria-causing parasite. This research led to the development of the first human vaccine for malaria, which the World Health Organization recently approved for use in Africa (via The New York Times). She published more than 200 scientific papers in her lifetime, most recently coauthoring a study in Scientific Reports on vaccines against Plasmodium vivax in January of this year.  

Nussenzweig is survived by her husband and three children.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.